Skip to Main Content

An official website of the United States government

Here you can browse the complete list of projects for PLCO whose requests for data/biospecimens were approved.

Name Principal Investigator Institution Study Date Approved Project ID
Genetic Risk of Mortality in Pancreatic Cancer Yan Ding City of Hope PLCO Apr 17, 2013 PLCO-27
Measures of tobacco use and nicotine dependency with total and cause-specific mortality in PLCO Neal Freedman NCI, DCEG, NEB PLCO Apr 16, 2013 PLCO-29
Mortality Reduction by year Rowena Yip Icahn School of Medicine at Mount Sinai PLCO Apr 15, 2013 PLCO-24
Energy Balance, Mortality and Healthy Survival (Updated) Martin Tammemagi Brock University / Henry Ford Health System PLCO Apr 5, 2013 PLCO-26
Assesing the risk of ovarian cancer using serial ultrasounds and transvaginal ultrasound Edward Atkinson Rice University PLCO Apr 2, 2013 PLCO-25
Dietary and Socioeconomic Risk Factors of Melanoma Mark Hyde Huntsman Cancer Institute PLCO Mar 29, 2013 PLCO-16
Utilizing high-dimensional data with genome-wide scan data to identify novel genetic susceptibility variants for colorectal cancer Ulrike Peters Fred Hutchinson Cancer Research Center PLCO Mar 28, 2013 PLCO-23
Sexually transmitted diseases and risk of head and neck cancer Anil Chaturvedi NCI, DCEG, IIB PLCO Mar 15, 2013 PLCO-20
Effect of bilater salpingo-oophorectomy on morbidity and mortality Amanda Black NCI, DCEG, EBP PLCO Mar 14, 2013 PLCO-19
Second Cancers Following Radiotherapy in Prostate Cancer Patients in the PLCO Amanda Black NCI, DCEG, EBP PLCO Mar 14, 2013 PLCO-18
Biliary Tract Cancers Pooling Project Jill Koshiol NCI, DCEG, IIB PLCO Mar 5, 2013 PLCO-17
Genetic Targeted Screening Prediction of Prostate Cancer Mortality A. Karim Kader University of California, San Diego PLCO Mar 5, 2013 PLCO-14
Evaluation of serum antibodies to Helicobacter pylori proteins and hepatobiliary cancers Gwen Murphy Imperial College London PLCO Mar 4, 2013 2013-0035
Genome wide epigenetic alteration study to identify biomarkers of smoking and bladder cancer risk Lee Moore NCI, DCEG, OEEB PLCO Mar 4, 2013 2013-0033
Anti-Mullerian Hormone and Prostate Cancer Risk Martha Sklavos NCI, DCEG, IIB PLCO Mar 4, 2013 2013-0008
Prostate Specific Antigen (PSA) Growth Curves: an Innovation to Improve Prostate Cancer Screening James Hebert University of South Carolina, Cancer Prevention and Control Program PLCO Feb 22, 2013 PLCO-15
Impact of Family History on Colorectal Cancer Incidence and Expression Robert Schoen University of Pittsburgh PLCO Jan 25, 2013 PLCO-13
Calcium intake and lung cancer: effect modification by sex and smoking status Yumie Takata Vanderbilt University PLCO Jan 24, 2013 PLCO-11
Mortality and Morbidity Following Prostate Biopsy Paul Pinsky NCI, DCP, EDRG PLCO Jan 17, 2013 PLCO-12
Cancer history and melanoma risk Sonja Berndt NCI, DCEG, OEEB PLCO Dec 13, 2012 PLCO-10